Pages that link to "Q73827515"

The following pages link to A sensitive and convenient method for lipoprotein profile analysis of individual mouse plasma samples (Q73827515):

Displaying 44 items.

• Proteasome activator PA28 gamma regulates p53 by enhancing its MDM2-mediated degradation (Q24319027) (← links)
• Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/II (Q24658096) (← links)
• A computational model for the analysis of lipoprotein distributions in the mouse: translating FPLC profiles to lipoprotein metabolism (Q28538300) (← links)
• A mutation in Ampd2 is associated with nephrotic syndrome and hypercholesterolemia in mice (Q28592410) (← links)
• Two apolipoprotein E mimetic peptides with similar cholesterol reducing properties exhibit differential atheroprotective effects in LDL-R null mice. (Q30535428) (← links)
• Lack of mitogen-activated protein kinase phosphatase-1 protects ApoE-null mice against atherosclerosis (Q33762645) (← links)
• Oral administration of L-mR18L, a single domain cationic amphipathic helical peptide, inhibits lesion formation in ApoE null mice. (Q34287846) (← links)
• ApoB-containing lipoproteins promote infectivity of chlamydial species in human hepatoma cell line (Q34391565) (← links)
• A CD36-dependent pathway enhances macrophage and adipose tissue inflammation and impairs insulin signalling (Q34530236) (← links)
• Nox2 modification of LDL is essential for optimal apolipoprotein B-mediated control of agr type III Staphylococcus aureus quorum-sensing. (Q34608010) (← links)
• Genetic demonstration of intestinal NPC1L1 as a major determinant of hepatic cholesterol and blood atherogenic lipoprotein levels (Q34674336) (← links)
• Anti-inflammatory mechanisms of apolipoprotein A-I mimetic peptide in acute respiratory distress syndrome secondary to sepsis. (Q34731730) (← links)
• Mitochondrial Oxidative Stress Significantly Influences Atherogenic Risk and Cytokine-Induced Oxidant Production (Q34980994) (← links)
• Atherosclerotic lesion progression is attenuated by reconstitution with bone marrow from macrophage-specific cholesteryl ester hydrolase transgenic mice (Q35395341) (← links)
• Lipidomic changes of LDL in overweight and moderately hypercholesterolemic subjects taking phytosterol- and omega-3-supplemented milk (Q35536385) (← links)
• CD36/SR-B2-TLR2 Dependent Pathways Enhance Porphyromonas gingivalis Mediated Atherosclerosis in the Ldlr KO Mouse Model (Q35566496) (← links)
• Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. (Q35606800) (← links)
• Apolipoprotein B48, the Structural Component of Chylomicrons, Is Sufficient to Antagonize Staphylococcus aureus Quorum-Sensing. (Q35622488) (← links)
• A spontaneous mutation in Srebf2 leads to cataracts and persistent skin wounds in the lens opacity 13 (lop13) mouse (Q35654048) (← links)
• Association of aortic atherosclerosis with cerebral beta-amyloidosis and learning deficits in a mouse model of Alzheimer's disease. (Q35843366) (← links)
• Probucol therapy overcomes the reproductive defect in CTP: phosphocholine cytidylyltransferase beta2 knockout mice (Q35944538) (← links)
• A novel truncated form of apolipoprotein A-I transported by dense LDL is increased in diabetic patients. (Q35994373) (← links)
• Macrophage-specific transgenic expression of cholesteryl ester hydrolase significantly reduces atherosclerosis and lesion necrosis in Ldlr mice (Q35995692) (← links)
• 25(OH)D3 and cardiovascular risk factors in female nonhuman primates (Q36352583) (← links)
• HDL Mimetic Peptide Administration Improves Left Ventricular Filling and Cardiac output in Lipopolysaccharide-Treated Rats (Q36447185) (← links)
• Applications of microfluidics and microchip electrophoresis for potential clinical biomarker analysis (Q36496717) (← links)
• Cholesteryl esters associated with acyl-CoA:cholesterol acyltransferase predict coronary artery disease in patients with symptoms of acute coronary syndrome (Q36593979) (← links)
• Significant genotype by diet (G × D) interaction effects on cardiometabolic responses to a pedigree-wide, dietary challenge in vervet monkeys (Chlorocebus aethiops sabaeus). (Q36721513) (← links)
• Effects of a Western-type diet on plasma lipids and other cardiometabolic risk factors in African green monkeys (Chlorocebus aethiops sabaeus). (Q37052240) (← links)
• Molecular cloning of hamster lipid transfer inhibitor protein (apolipoprotein F) and regulation of its expression by hyperlipidemia (Q37130807) (← links)
• Quercetin prevents left ventricular hypertrophy in the Apo E knockout mouse (Q37133557) (← links)
• Hyphenating size-exclusion chromatography with electrospray mass spectrometry; using on-line liquid-liquid extraction to study the lipid composition of lipoprotein particles (Q37152209) (← links)
• Apolipoprotein A-I mimetic peptide treatment inhibits inflammatory responses and improves survival in septic rats (Q37298363) (← links)
• Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions (Q37486465) (← links)
• Targeting GGTase-I activates RHOA, increases macrophage reverse cholesterol transport, and reduces atherosclerosis in mice (Q37613222) (← links)
• MicroRNA-144 regulates hepatic ATP binding cassette transporter A1 and plasma high-density lipoprotein after activation of the nuclear receptor farnesoid X receptor (Q38898464) (← links)
• Multidimensional profiling of plasma lipoproteins by size exclusion chromatography followed by reverse-phase protein arrays (Q39234722) (← links)
• An apoA-I mimetic peptibody generates HDL-like particles and increases alpha-1 HDL subfraction in mice (Q42119788) (← links)
• Effect of Synthetic High Density Lipoproteins Modification with Polyethylene Glycol on Pharmacokinetics and Pharmacodynamics. (Q48298889) (← links)
• Influence of route of administration and lipidation of apolipoprotein A-I peptide on pharmacokinetics and cholesterol mobilization. (Q51306832) (← links)
• Novel fatty acyl apoE mimetic peptides have increased potency to reduce plasma cholesterol in mice and macaques (Q58752719) (← links)
• TNF-related apoptosis-inducing ligand (TRAIL) protects against diabetes and atherosclerosis in Apoe −/− mice (Q63915339) (← links)
• Therapeutic silencing of FSP27 reduces the progression of atherosclerosis in Ldlr-/- mice (Q88958207) (← links)
• ApoF knockdown increases cholesteryl ester transfer to LDL and impairs cholesterol clearance in fat-fed hamsters (Q90068241) (← links)